Abstract
Economic evaluations are tools for assessing emerging technologies and a complement for decision-making in healthcare systems. However, this topic may not be familiar for doctors and academics, who may be confused when interpreting the results of studies using these tools. Cataract is a disease which has received special attention in healthcare systems due to its high incidence, the great impact that it could have on patients’ quality of life, and the fact that it can be definitively solved in almost all cases through cataract surgery. Historically, economic evaluations in cataract surgery have been conducted for many purposes by simply assessing whether the surgery is cost-effective for specific questions related to the implantation of multifocal intraocular lenses, surgical techniques, optimizing assessments, preventing diseases or complications, etc. Moreover, although there are systematic reviews about cataract surgery and narrative reviews introducing the concept of economic evaluations, as far as we know, no previous study has been conducted that synthesizes and integrates evidence coming from both fields. Thus, the purpose of this narrative review is to introduce doctors and academics to economic evaluation tools, to describe how these have been historically applied to cataract surgery, and to provide special considerations for the correct interpretation of economic studies.
摘要
经济评价是评估新兴技术的工具, 也是医保系统决策的补充。然而, 医生和学者对此并不熟悉, 他们在使用这些工具解释研究结果时可能会感到困惑。白内障是在医疗系统中受到特别关注的眼病, 因为其发病率高, 对患者的生活质量影响大, 几乎所有 (因白内障视力低下的) 病例都可以通过白内障手术解决。从历史上看, 白内障手术的经济评价有很多目的, 通过简单地评估手术是否具有成本效益来解决与多焦人工晶状体植入、手术技术、优化评估、预防疾病或并发症等相关的特定问题。此外, 尽管有关于白内障手术的系统综述和引入经济评价概念的综述, 但目前还没有综合和整合这两个领域证据的研究。因此, 本叙述性综述旨在向医生和学者介绍经济评价工具, 描述这些工具在历史上如何应用于白内障手术, 并提供正确解读经济研究的特别注意事项。
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 18 print issues and online access
$259.00 per year
only $14.39 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Goodacre SW, McCabe C. An introduction to economic evaluation. Emerg Med J 2002;19:198–201.
Jonsson B. Economic evaluation of health care technologies. Acta Endocrinol. 1993;128:50–54.
Ko F, Frick KD, Tzu J, He M, Congdon N. Willingness to pay for potential enhancements to a low-cost cataract surgical package in rural southern China. Acta Ophthalmol. 2012;90:e54–e60. https://www.embase.com/search/results?subaction=viewrecord&id=L51553590&from=export.
Dean WH, Sherwin JC, Kumwenda S, Angeletti M, Wiehler U. Willingness to Pay for Cataract Surgery in Post-operative Cataract Patients in Rural Malawi. Ophthalmic Epidemiol. 2012;19:265–71. https://www.embase.com/search/results?subaction=viewrecord&id=L365658140&from=export.
Shrestha MK. Willingness to pay for cataract surgery in Kathmandu valley. Br J Ophthalmol. 2004;88:319–20. https://www.embase.com/search/results?subaction=viewrecord&id=L38333704&from=export.
Brown GC, Brown MM, Menezes A, Busbee BG, Lieske HB, Lieske PA. Cataract Surgery Cost Utility Revisited in 2012. Ophthalmology. 2013;120:2367–76. https://pubmed.ncbi.nlm.nih.gov/24246824/.
Brown GC, Brown MM, Busbee BG. Cost-utility analysis of cataract surgery in the United States for the year 2018. J Cataract Refract Surg. 2019;45:927–38. https://pubmed.ncbi.nlm.nih.gov/31262482/.
Busbee BG, Brown MM, Brown GC, Sharma S. Incremental cost-effectiveness of initial cataract surgery. Ophthalmology. 2002;109:606–12. https://pubmed.ncbi.nlm.nih.gov/11874769/.
Hiratsuka Y. Cost-utility analysis of cataract surgery in Japan: A probabilistic Markov modeling study. Jpn J Ophthalmol. 2013;57:391–401. https://doi.org/10.1007/s10384-013-0238-8.
Tuominen R, Immonen I, Raivio I. Economic evaluation of cataract surgery: a comparison between IOL and non-IOL techniques. Acta Ophthalmol. 1988;66:577–81.
Griffiths UK, Bozzani FM, Gheorghe A, Mwenge L, Gilbert C. Cost-effectiveness of eye care services in Zambia. Cost Eff Resour Alloc. 2014;12:6 https://pubmed.ncbi.nlm.nih.gov/24568593/.
Marseille E. Cost-effectiveness of cataract surgery in a public health eye care programme in Nepal. Bull World Health Organ. 1996;74:319–24.
Moore DB, Slabaugh MA. Surgical Outcomes and Cost Basis for Resident-Performed Cataract Surgery in an Uninsured Patient Population. JAMA Ophthalmol. 2013;131:891.
Agarwal A, Kumar DA. Cost-effectiveness of cataract surgery. Curr Opin Ophthalmol. 2011;22:15–8.
Schulz CB, Kennedy A, Rymer BC. Trends in ophthalmology journals: a five-year bibliometric analysis (2009-2013). Int J Ophthalmol. 2016;9:1669–75. http://www.ijo.cn/gjyken/ch/reader/view_abstract.aspx?file_no=20161122&flag=1.
Wen P-F, Dong Z-Y, Li B-Z, Jia Y-Q. Bibliometric analysis of literature on cataract research in PubMed (2001–2013). J Cataract Refract Surg 2015;41:1781–3. https://journals.lww.com/02158034-201508000-00031.
Guillemin F, De Wit M, Fautrel B, Grimm S, Joore M, Boonen A. Steps in implementing a health economic evaluation. RMD Open. 2020;6:6–8.
Turner HC, Archer RA, Downey LE, Isaranuwatchai W, Chalkidou K, Jit M, et al. An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare: Key Features, Uses, and Limitations. Front Public Heal. 2021;9:1–17.
Kapse R, Agarwal S, Rishikeshi N, Deshpande M, Kulkarni S, Deshpand R, et al. Cost analysis of pediatric cataract surgery in a tertiary eye care hospital in Western India. Indian J Ophthalmol. 2022;70:420 https://pubmed.ncbi.nlm.nih.gov/35086208/.
UK Health Security Agency. Cost consequence analysis: health economic studies. Guidance. 2020. Available at: https://www.gov.uk/guidance/cost-consequence-analysis-health-economic-studies. Accessed August 4, 2022.
Neel ST. A cost-minimization analysis comparing immediate sequential cataract surgery and delayed sequential cataract surgery from the payer, patient, and societal perspectives in the United States. JAMA Ophthalmol. 2014;132:1282–8.
Cernat A, Jamieson M, Kavelaars R, Khalili S, Bhambhwani V, Mireskandari K, et al. Immediate versus delayed sequential bilateral cataract surgery in children: a cost-effectiveness analysis. Br J Ophthalmol 2022;106:211–7. https://www.embase.com/search/results?subaction=viewrecord&id=L633488887&from=export.
Neel ST. A cost and policy analysis comparing immediate sequential cataract surgery and delayed sequential cataract surgery from the physician perspective in the United States. JAMA Ophthalmol. 2014;132:1359–62.
UK Health Security Agency. Cost effectiveness analysis: health economic studies. Guidance. 2020. Available at: https://www.gov.uk/guidance/cost-effectiveness-analysis-health-economic-studies. Accessed August 4, 2022.
Quist SW, de Jong LA, van Asten F, Knoester P, Postma MJ, Freriks RD. Cost-minimisation analysis of a treat-and-extend regimen with anti-VEGFs in patients with neovascular age-related macular degeneration. Graefe’s Arch Clin Exp Ophthalmol. 2022;260:1083–95. https://doi.org/10.1007/s00417-021-05359-x.
Ngan K, Fraser E, Buller S, Buller A. A cost minimisation analysis comparing iStent accompanying cataract surgery and selective laser trabeculoplasty versus topical glaucoma medications in a public healthcare setting in New Zealand. Graefe’s Arch Clin Exp Ophthalmol. 2018;256:2181–9. http://link.springer.com/10.1007/s00417-018-4104-8.
Maxwell WA, Waycaster CR, D’Souza AO, Meissner BL, Hileman K. A United States cost–benefit comparison of an apodized, diffractive, presbyopia-correcting, multifocal intraocular lens and a conventional monofocal lens. J Cataract Refract Surg. 2008;34:1855–61. https://pubmed.ncbi.nlm.nih.gov/19006730/.
UK Health Security Agency. Cost utility analysis: health economic studies. Guidance. 2020. Available at: https://www.gov.uk/guidance/cost-utility-analysis-health-economic-studies. Accessed August 4, 2022.
UK Health Security Agency. Cost benefit analysis: health economic studies. Guidance. 2020. Available at: https://www.gov.uk/guidance/cost-benefit-analysis-health-economic-studies. Accessed August 4, 2022.
Webb J, Fife-Schaw C, Ogden J. A randomised control trial and cost-consequence analysis to examine the effects of a print-based intervention supported by internet tools on the physical activity of UK cancer survivors. Public Health. 2019;171:106–15. https://linkinghub.elsevier.com/retrieve/pii/S0033350619301143.
Torrance GW. Utility approach to measuring health-related quality of life. J Chronic Dis. 1987;40:593–600.
Drummond MF. Economic aspects of cataract. Ophthalmology. 1988;95:1147–53. https://pubmed.ncbi.nlm.nih.gov/3148114/.
Brown GC. Vision and quality-of-life. Trans. Am Ophthalmol Soc. 1999;97:473–511.
Lansingh VC. Use of Global Visual Acuity Data in a Time Trade-off Approach to Calculate the Cost Utility of Cataract Surgery. Arch Ophthalmol. 2009;127:1183 https://pubmed.ncbi.nlm.nih.gov/19752429/.
Eye Care Comparative Effectiveness Research Team (ECCERT). Cost-effectiveness of cataract surgery in Japan. Jpn J Ophthalmol. 2011;55:333–42. https://doi.org/10.1007/s10384-011-0041-3.
Tahhan N, Papas E, Fricke T, Frick K, Holden B. Utility and uncorrected refractive error. Investig. Ophthalmol Vis Sci. 2013;54. Available at: https://www.embase.com/search/results?subaction=viewrecord&id=L628731005&from=export.
Kobelt G, Lundström M, Stenevi U. Cost-effectiveness of cataract surgery. J Cataract Refract Surg. 2002;28:1742–9. https://journals.lww.com/02158034-200210000-00021.
Brown GC, Brown MM, Chaudhry I, Stein JD. Opportunities to Reduce Potential Bias in Ophthalmic Cost-Utility Analysis. JAMA Ophthalmol. 2021;139:389 https://pubmed.ncbi.nlm.nih.gov/33538789/.
Weale M. A cost-benefit analysis of cataract surgery based on the English Longitudinal Survey of Ageing. J Health Econ. 2011;30:730–9.
Lugnér AK, Krabbe PFM. An overview of the time trade-off method: concept, foundation, and the evaluation of distorting factors in putting a value on health. Expert Rev Pharmacoeconomics Outcomes Res. 2020;20:331–42. https://doi.org/10.1080/14737167.2020.1779062.
Arnesen TM, Norheim OF. Quantifying quality of life for economic analysis: Time out for time trade off. Med Humanit. 2003;29:81–6.
Leung EH, Gibbons A, Koch DD. Cost-Effectiveness of Preoperative OCT in Cataract Evaluation for Multifocal Intraocular Lens. Ophthalmology. 2020;127:859–65. https://pubmed.ncbi.nlm.nih.gov/32173111/.
Räsänen P, Krootila K, Sintonen H, Leivo T, Koivisto AM, Ryynänen OP, et al. Cost-utility of routine cataract surgery. Health Qual Life Outcomes. 2006;4:74.
Asakawa K, Rolfson D, Senthilselvan A, Feeny D, Johnson JA. Health Utilities Index Mark 3 showed valid in Alzheimer Disease, arthritis, and cataracts. J Clin Epidemiol. 2008;61:733–9.
Schweitzer C, Brezin A, Cochener B, Monnet D, Germain C, Roseng S, et al. Femtosecond laser-assisted versus phacoemulsification cataract surgery (FEMCAT): a multicentre participant-masked randomised superiority and cost-effectiveness trial. Lancet. 2020;395:212–24.
Lin CC, Rose-Nussbaumer JR, Al-Mohtaseb ZN, Pantanelli SM, Steigleman WA, Hatch KM, et al. Femtosecond Laser-Assisted Cataract Surgery. Ophthalmology. 2022;129:946–54. https://pubmed.ncbi.nlm.nih.gov/35570159/.
Day AC, Burr JM, Bennett K, Dore CJ, Bunce C, Hunter R, et al. Femtosecond laser-assisted cataract surgery compared with phacoemulsification cataract surgery: randomized noninferiority trial with 1-year outcomes. J Cataract Refract Surg. 2020;46:1360–7.
Larco P, Larco C, Borroni D, Godin F, Piñero DP, Rocha-de-Lossada C, et al. Efficacy of femtosecond laser for anterior capsulotomy in complex white cataracts. J Fr Ophtalmol. 2023;46:501–9. https://linkinghub.elsevier.com/retrieve/pii/S0181551223000487.
Abell RG, Vote BJ. Cost-Effectiveness of Femtosecond Laser-Assisted Cataract Surgery versus Phacoemulsification Cataract Surgery. Ophthalmology. 2014;121:10–16. https://pubmed.ncbi.nlm.nih.gov/24120324/.
Jongsareejit A, Wiriyaluppa C, Kongsap P, Phumipan S. Cost-effectiveness analysis of manual small incision cataract surgery (MSICS) and phacoemulsification (PE). J Med Assoc Thail. 2012;95:212–20. https://pubmed.ncbi.nlm.nih.gov/22435252/.
Khan A, Amitava A, Rizvi SA, Siddiqui Z, Kumari N, Grover S. Cost-effectiveness analysis should continually assess competing health care options especially in high volume environments like cataract surgery. Indian J Ophthalmol. 2015;63:496. https://www.embase.com/search/results?subaction=viewrecord&id=L615153888&from=export.
Rochmah TN, Wulandari A, Dahlui M, Ernawaty, Wulandari RD. Cost Effectiveness Analysis Using Disability-Adjusted Life Years for Cataract Surgery. Int J Environ Res Public Health. 2020;17:6010. https://pubmed.ncbi.nlm.nih.gov/32824872/.
Wulandari A, Dahlui M, E, Wulandari RD, Rochmah TN. Cost effectiveness analysis between small incision cataract surgery and phacoemulsification. J Heal Transl Med. 2020;23:231–7. https://jummec.um.edu.my/index.php/jummec/article/view/25860.
Manaf MRA, Aljunid SM, Annuar FH, Leong CK, Mansor N. Cost-effectiveness analysis of cataract surgery with intraocular lens implantation: Extracapsular cataract extraction versus phacoemulsification. Med J Indones. 2007;16:25–31.
Baltussen R, Sylla M, Mariotti SP. Cost-effectiveness analysis of cataract surgery: a global and regional analysis. Bull World Health Organ. 2004;82:338–45.
Rizal AM, Aljunid SM, Normalina M, Hanom AF, Chuah KL, Suzainah Y, et al. Cost analysis of cataract surgery with intraocular lens implantation: a single blind randomised clinical trial comparing extracapsular cataract extraction and phacoemulsification. Med J Malays. 2003;58:380–6. https://pubmed.ncbi.nlm.nih.gov/14750378/.
Asimakis P, Coster DJ, Lewis DJ. Cost effectiveness of cataract surgery. A comparison of conventional extracapsular surgery and phacoemulsification at Flinders Medical Centre. Aust N Z J Ophthalmol. 1996;24:319–25.
Kristianslund O, Dalby M, Moe MC, Drolsum L. Cost‐effectiveness analysis in a randomized trial of late in‐the‐bag intraocular lens dislocation surgery: repositioning versus exchange. Acta Ophthalmol. 2019;97:771–7. https://www.embase.com/search/results?subaction=viewrecord&id=L627183345&from=export.
Malvankar-Mehta MS, Filek R, Iqbal M, Shakir A, Mao A, Si F, et al. Immediately sequential bilateral cataract surgery: a cost-effective procedure. Can J Ophthalmol 2013;48:482–8. https://pubmed.ncbi.nlm.nih.gov/24314408/.
Lundström M, Albrecht S, Roos P. Immediate versus delayed sequential bilateral cataract surgery: an analysis of costs and patient value. Acta Ophthalmol. 2009;87:33–8.
Sach TH, Foss AJE, Gregson RM, Zaman A, Osborn F, Masud T, et al. Second-eye cataract surgery in elderly women: a cost-utility analysis conducted alongside a randomized controlled trial. Eye. 2010;24:276–83. https://pubmed.ncbi.nlm.nih.gov/19444295/.
Busbee BG, Brown MM, Brown GC, Sharma S. Cost-utility analysis of cataract surgery in the second eye. Ophthalmology. 2003;110:2310–7. https://pubmed.ncbi.nlm.nih.gov/14644712/.
Boyd M, Kvizhinadze G, Kho A, Wilson G, Wilson N. Cataract surgery for falls prevention and improving vision: modelling the health gain, health system costs and cost-effectiveness in a high-income country. Inj Prev. 2020;26:302–9. https://www.embase.com/search/results?subaction=viewrecord&id=L628439610&from=export.
Boyd M, Kho A, Wilson G, Wilson N. Expediting cataract surgery in New Zealand is cost-effective for falls prevention and improving vision-so what might be the next steps? N Z Med J. 2019;132:73–8. https://www.embase.com/search/results?subaction=viewrecord&id=L629200987&from=export.
Frampton G, Harris P, Cooper K, Lotery A, Shepherd J, GF, et al. The clinical effectiveness and cost-effectiveness of second-eye cataract surgery: a systematic review and economic evaluation. Health Technol Assess. 2014;18:1–206. https://www.journalslibrary.nihr.ac.uk/hta/hta18680/.
Meltzer ME, Congdon N, Kymes SM, Yan X, Lansingh VC, Sisay A, et al. Cost and Expected Visual Effect of Interventions to Improve Follow-up After Cataract Surgery. JAMA Ophthalmol. 2017;135:85 https://pubmed.ncbi.nlm.nih.gov/27978578/.
Jastrzebski A, Villafranca A, Sethi S, Bellan L. Safety and comparative costs of preoperative assessments for cataract surgery: traditional mandatory assessment versus a novel graded assessment system. Can J Anesth. 2016;63:842–50.
Naeim A, Keeler EB, Gutierrez PR, Wilson MR, Reuben D, Mangione CM. Is cataract surgery cost-effective among older patients with a low predicted probability for improvement in reported visual functioning? Med Care. 2006;44:982–9.
Dimock J, Robman LD, McCarty CA, Taylor HR. Cost-effectiveness of digital cataract assessment. Aust N Z J Ophthalmol. 1999;27:208–10. https://doi.org/10.1046/j.1440-1606.1999.00207.x.
Hopkins RB, Tarride J-E, Bowen J, Blackhouse G, O’Reilly D, Campbell K, et al. Cost-effectiveness of reducing wait times for cataract surgery in Ontario. Can J Ophthalmol. 2008;43:213–7. https://pubmed.ncbi.nlm.nih.gov/18347625/.
Jain S, Chauhan A, Rajshekar K, Vashist P, Gupta P, Mathur U, et al. Generic and vision related quality of life associated with different types of cataract surgeries and different types of intraocular lens implantation. PLoS One. 2020;15:e0240036.
Smith AF, Lafuma A, Berdeaux G, Berto P, Brueggenjuergen B, Magaz S, et al. Cost-effectiveness analysis of PMMA, silicone, or acrylic intra-ocular lenses in cataract surgery in four European countries. Ophthalmic Epidemiol. 2005;12:343–51. https://pubmed.ncbi.nlm.nih.gov/16272054/.
Colin J, Praud D, Touboul D, Schweitzer C. Incidence of glistenings with the latest generation of yellow-tinted hydrophobic acrylic intraocular lenses. J Cataract Refract Surg. 2012;38:1140–6. https://doi.org/10.1016/j.jcrs.2012.01.031.
Simons RWP, Visser N. van den Biggelaar FJHM, Nuijts RMMA, Webers CAB, Bauer NJC, et al. Trial-based cost-effectiveness analysis of toric versus monofocal intraocular lenses in cataract patients with bilateral corneal astigmatism in the Netherlands. J Cataract Refract Surg. 2019;45:146–52.
Orme ME, Paine AC, Teale CW, Kennedy LM. Cost-effectiveness of the AMOArray Multifocal Intraocular Lens in Cataract Surgery. J Refract Surg. 2002;18:162–8. https://pubmed.ncbi.nlm.nih.gov/30471848/.
Hu JQ, Sarkar R, Murphy J, Afshari NA. Cost-effectiveness of multifocal intraocular lenses compared to monofocal intraocular lenses in cataract surgery. Investig Ophthalmol Vis Sci. 2018;59. https://www.embase.com/search/results?subaction=viewrecord&id=L628536790&from=export.
Athanasiov P, Bala C, Holland J, Dhariwal M, Gupta A, Rathi H. A cost-effectiveness analysis of AcrySof IQ vivity intraocular lens from private health fund perspective in Australia. Clin Ophthalmol. 2022;49:878–9.
Dobrez DG, Calhoun EA. Testing subject comprehension of utility questionnaires. Qual Life Res. 2004;13:369–76.
Lin J-C, Yang M-C. Cost-Effectiveness Comparison Between Monofocal and Multifocal Intraocular Lens Implantation for Cataract Patients in Taiwan. Clin Ther. 2014;36:1422–30. https://pubmed.ncbi.nlm.nih.gov/25146366/.
De Vries NE, Laurendeau C, Lafuma A, Berdeaux G, Nuijts RMMA. Lifetime costs and effectiveness of ReSTOR compared with a monofocal IOL and Array-SA40 in the Netherlands. Eye. 2010;24:663–72. https://pubmed.ncbi.nlm.nih.gov/19575029/.
Lafuma A, Berdeaux G. Modelling lifetime cost consequences of ReSTOR in cataract surgery in four European countries. BMC Ophthalmol. 2008;8:12.
Simons RWP, Wielders LHP, Nuijts RMMA, Veldhuizen CA, van den Biggelaar FJHM, Winkens B, et al. Economic evaluation of prevention of cystoid macular edema after cataract surgery in diabetic patients: ESCRS PREMED study report 6. J Cataract Refract Surg. 2022;48:555–63. https://pubmed.ncbi.nlm.nih.gov/33009281/.
Author information
Authors and Affiliations
Contributions
Concept and design: Ginel, Burguera, Fernández; Acquisition of data: Ginel, Burguera; Analysis and interpretation of data: Ginel, Burguera, Piñero, Sáez-Martín, Haro De Rosario, Fernández; Drafting of the manuscript: Ginel, Burguera, Fernández; Critical revision of the paper for important intellectual content: Piñero, Sáez-Martín, Haro De Rosario; Obtaining funding: Fernández; Administrative, technical, or logistic support: Fernández; Supervision: Piñero, Sáez-Martín, Haro De Rosario, Fernández.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ginel, J., Burguera, N., Piñero, D. et al. Economic evaluations in cataract surgery: a narrative review. Eye (2024). https://doi.org/10.1038/s41433-024-02965-x
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41433-024-02965-x